By Michelle RobertsDigital health editor
Getty ImagesA diabetes medicine dubbed the “King Kong” of weight loss jabs has been approved in the UK for treating obesity.
Mounjaro, or tirzepatide, makes you feel fuller so you eat less.
In trials, people on it have lost a fifth of their body weight and UK regulators now say it is safe and effective enough to be sold and prescribed in the UK.
Unlike a similar jab called Wegovy, it is not recommended on the NHS yet.
The NHS can use it for diabetes though.
Healthcare spending watchdog The National Institute for Health and Care Excellence (NICE) is reviewing its use for obesity and should report back in March 2024.
Both Wegovy and Mounjaro, which work in similar ways, come as pre-filled injection pens that patients can self-administer – giving themselves a dose under the skin of their stomach area or thigh.
They can help people shed significant weight.
But, in studies, users often put weight back…
